Skip to main content
SER filings

Corporate insider profile

Stephen K. Brannan Filing Activity

Latest reported as Corporate insider of Serina Therapeutics, Inc. (SER).

Purchase filings
1
Reported companies
1
Net open-market value
$2,030
Latest transaction
Jul 7, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 7, 2026Serina Therapeutics, Inc. (SER)Corporate insiderOpen Market Purchase1,000$2.03$2,030